Skip to content

Cassia Cinnamon for Glucose Uptake in Young Women

Cassia Cinnamon and Acute Endurance Exercise for the Enhancement of Glucose Uptake in Healthy Young Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00951639
Enrollment
10
Registered
2009-08-04
Start date
2008-02-29
Completion date
2009-05-31
Last updated
2022-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impaired Glucose Tolerance, Insulin Resistance, Prediabetes

Keywords

Cassia, Cinnamon, Blood Glucose, Endurance exercise, Acute exercise, Overweight, Obesity, Women

Brief summary

The purpose of this study was to compare the acute effects of 5g of Cassia cinnamon, 50 minutes of endurance exercise performed at 70% of the heart rate reserve (correlated to VO2max), and 5g of cellulose placebo on blood glucose, serum insulin and insulin sensitivity following an oral glucose tolerance test 3 hours after administration of each intervention.

Interventions

DIETARY_SUPPLEMENTCassia cinnamon

5g encapsulated ground bark administered once in experimental session

PROCEDURE50 minutes exercise

50 minutes treadmill endurance exercise at 70% of the heart rate reserve (correlated to VO2max)

DIETARY_SUPPLEMENTCellulose Powder

5g encapsulated powder administered during placebo experimental session

Sponsors

Baylor University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Sedentary * BMI: 27-45 * DXA body fat % greater than 30% * 18-30 years of age * Healthy * From the Baylor University campus and surrounding community * Regular sleep habits

Exclusion criteria

* Not regular users of any species of cinnamon * Not diagnosed with any metabolic disorder or chronic medical condition * Not taking prescription medications for 2 months before the study * Not taking ergogenic aids for 2 months before the study * Not taking oral contraceptives for 2 months before the study * No IUD placed for 2 months before the study

Design outcomes

Primary

MeasureTime frame
Blood GlucoseBaseline, 0, 30, 60, 90 and 120 minutes following OGTT

Secondary

MeasureTime frame
Serum InsulinBaseline, 0, 30, 60, 90 and 120 minutes following OGTT

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026